An Update on the Epidemiology of Schizophrenia with a Special Reference to Clinically Important Risk Factors

International Journal of Mental Health and Addiction

Volumn 9, Issue 1, 2011, Pages 39-59

  El Missiry, Ahmed ^a   Aboraya, Ahmed Sayed ^a   Manseur, Hader ^a   Manchester, Johnna ^a   France, Cheryl ^a   Border, Katherine ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia praecox; Epidemiology; Incidence; Prevalence; Schizophrenia

Indexed keywords

EID: 79651472328     PISSN: 15571874     EISSN: 15571882     Source Type: Journal    
DOI: 10.1007/s11469-009-9241-1     Document Type: Article

References (163)

1. Aboraya, A., & Tien, A. (November 2004). Schedules for Clinicians' Interviews in Psychiatry (SCIP): Work in Progress. eCOMMUNITY: International Journal of Mental Health and Addiction.
2. Aboraya, A., & Zheng, W. (2007). The Schedules for Clinicians' Interview in Psychiatry (SCIP): A new innovative educational tool with dual funtion: clinical management and research. Proceeding of Association For Academic Psychiatry Annual Meeting, Boston, MA.
3. Aboraya, A., Rankin, E., France, C., El-Missiry, A., & Collin, J. (2006). The reliability of psychiatric diagnosis revisited: the clinician's guide to improve the reliability of psychiatric diagnosis. Psychiatry, 3, 41-50.
4. Ahokas, A., Aito, M., & Rimón, R. (2000). Positive treatment effect of estradiol in postpartum psychosis: a pilot study. The Journal of Clinical Psychiatry, 61(3), 166-169.
5. Aleman, A., Kahn, R. S., & Selten, J. (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry, 60(6), 565-571.
6. American Psychiatric Association. (1952). Diagnostic and Statistical Manual of Mental Disorders, First Edition (1st ed.). Washington, D. C.
7. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington: American Psychiatric Association.
8. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, text revised (4th ed.). Washington: American Psychiatric Association.
9. Andreasen, N. C., & Black, D. W. (2001). Introductory textbook of psychiatry (3rd ed.). Washington: American Psychiatric.
10. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal (Clinical Research Ed.), 325(7374), 1212-1213.
11. Badner, J. A., & Gershon, E. S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7(4), 405-411.
12. Baker, A., Bucci, S., Lewin, T. J., Richmond, R., & Carr, V. J. (2005). Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research, 134(3), 241-250.
13. Bamrah, J. S., Freeman, H. L., & Goldberg, D. P. (1991). Epidemiology of schizophrenia in Salford, 1974-1984. Changes in an urban community over ten years. The British Journal of Psychiatry: The Journal of Mental Science, 159, 802-810.
14. Baron, M. (2001). Genetics of schizophrenia and the new millennium: progress and pitfalls. American Journal of Human Genetics, 68(2), 299-312.
15. Beer, M. D. (1995). The importance of the social and intellectual contexts in a discussion of the history of the concept of psychosis. Psychological Medicine, 25(2), 317-321.
16. Beer, M. D. (1996). Psychosis: a history of the concept. Comprehensive Psychiatry, 37(4), 273-291.
17. Beiser, M., & Iacono, W. G. (1990). An update on the epidemiology of schizophrenia. Canadian Journal of Psychiatry, 35(8), 657-668.
18. Bland, R. C. (1977). Demographic aspects of functional psychoses in Canada. Acta Psychiatrica Scandinavica, 55(5), 369-380.
19. Blouin, J. L., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., et al. (1998). Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nature Genetics, 20(1), 70-73.
20. Bowers, M., Boutros, N., D'Souza, D. C., & Madonick, S. (2001). Substance abuse as a risk factor for schizophrenia and related disorders. International Journal of Mental Health, 30, 33-57.
21. Boydell, J., van Os, J., Lambri, M., Castle, D., Allardyce, J., McCreadie, R. G., et al. (2003). Incidence of schizophrenia in south-east London between 1965 and 1997. The British Journal of Psychiatry: The Journal of Mental Science, 182, 45-49.
22. Bray, I., Waraich, P., Jones, W., Slater, S., Goldner, E. M., & Somers, J. (2006). Increase in schizophrenia incidence rates: findings in a Canadian cohort born 1975-1985. Social Psychiatry and Psychiatric Epidemiology, 41(8), 611-618.
23. Brewin, J., Cantwell, R., Dalkin, T., Fox, R., Medley, I., Glazebrook, C., et al. (1997). Incidence of schizophrenia in Nottingham. A comparison of two cohorts, 1978-1980 and 1992-1994. The British Journal of Psychiatry: The Journal of Mental Science, 171, 140-144.
24. Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W., Honer, W. G., & Bassett, A. S. (2000). Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science, 288, 678-682.
25. Bühler, B., Hambrecht, M., Löffler, W., an der Heiden, W., & Häfner, H. (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research, 54(3), 243-251.
26. Byrne, M., Agerbo, E., Eaton, W. W., & Mortensen, P. B. (2004). Parental socio-economic status and risk of first admission with schizophrenia-a Danish national register based study. Social Psychiatry and Psychiatric Epidemiology, 39(2), 87-96.
27. Cao, Q., Martinez, M., Zhang, J., Sanders, A. R., Badner, J. A., Cravchik, A., et al. (1997). Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics, 43(1), 1-8.
28. Cardno, A. G., & Gottesman, I. I. (2000). Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. American Journal of Medical Genetics, 97(1), 12-17.
29. Castle, D. J., & Murray, R. M. (1993). The epidemiology of late-onset schizophrenia. Schizophrenia Bulletin, 19(4), 691-700.
30. Castle, D., Wessely, S., Der, G., & Murray, R. M. (1991). The incidence of operationally defined schizophrenia in Camberwell, 1965-1984. The British Journal of Psychiatry, 159, 790-794.
31. Chien, I., Chou, Y., Lin, C., Bih, S., Chou, P., & Chang, H. (2004). Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996-2001. Psychiatry and Clinical Neurosciences, 58(6), 611-618.
32. Cho, J. J., Iannucci, F. A., Fraile, M., Franco, J., Alesius, T. N., & Stefano, G. B. (2003). The role of the estrogen in neuroprotection: implications for neurodegenerative diseases. Neuro Endocrinology Letters, 24(3-4), 141-147.
33. Chowdari, K. V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., et al. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics, 11(12), 1373-1380.
34. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 99(21), 13675-13680.
35. Cooper, J. (1970). Use of a procedure for standardizing psychiatric diagnosis. In E. Hare & J. K. Wings (Eds.), Psychiatric epidemiology (pp. 109-131). London: Oxford University Press.
36. Cooper, J. E., Kendell, R. E., Gurland, B. J., Sharpe, L., Copeland, J. R. M., & Simon, R. (1972). Psychiatric diagnosis in New York and London: A comparative study of mental hospital admissions. London: Oxford University Press.
37. Crow, T. J. (1995). A continuum of psychosis, one human gene, and not much else-the case for homogeneity. Schizophrenia Research, 17(2), 135-145.
38. Dalman, C., Allebeck, P., Cullberg, J., Grunewald, C., & Köster, M. (1999). Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Archives of General Psychiatry, 56(3), 234-240.
39. Di Paolo, T., Carmichael, R., Labrie, F., & Raynaud, J. P. (1979). Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain. Molecular and Cellular Endocrinology, 16(2), 99-112.
40. Dohrenwend, B., & Dohrenwend, B. (1969). Social status and psychological disorder: A causal inquiry. New York: Wiley.
41. Dohrenwend, B. P., Levav, I., & Shrout, P. E. (1986). Screening scales from the psychiatric epidemiology research interview (PERI). In M. M. Weissman, J. K. Myers & C. E. Ross (Eds.), Community surveys of psychiatric disorders (pp. 349-375). New Brunswick: Rutgers University Press.
42. Dufy, B., Vincent, J. D., Fleury, H., Du Pasquier, P., Gourdji, D., & Tixier-Vidal, A. (1979). Dopamine inhibition of action potentials in a prolactin secreting cell line is modulated by oestrogen. Nature, 282(5741), 855-857.
43. Eaton, W. W. (1974). Residence, social class, and schizophrenia. Journal of Health and Social Behavior, 15(4), 289-299.
44. Eaton, W. W. (1985). Epidemiology of schizophrenia. Epidemiologic Reviews, 7, 105-126.
45. Eaton, W., & Harrison, G. (2001). Life chances, life planning and schizophrenia: a review and interpretation of research on social deprivation. International Journal of Mental Health, 30, 58-81.
46. Endo, M., Daiguji, M., Asano, Y., Yamashita, I., & Takahashi, S. (1978). Periodic psychosis recurring in association with menstrual cycle. The Journal of Clinical Psychiatry, 39(5), 456-466.
47. Fouskakis, D., Gunnell, D., Rasmussen, F., Tynelius, P., Sipos, A., & Harrison, G. (2004). Is the season of birth association with psychosis due to seasonal variations in foetal growth or other related exposures? A cohort study. Acta Psychiatrica Scandinavica, 109(4), 259-263.
48. Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001). Neuroprotection by estradiol. Progress in Neurobiology, 63(1), 29-60.
49. Geddes, J. R., & Lawrie, S. M. (1995). Obstetric complications and schizophrenia: a meta-analysis. The British Journal of Psychiatry: The Journal of Mental Science, 167(6), 786-793.
50. Goldberg, D. P. (1972). Detection of psychiatric illness by questionnaire. Oxford: Oxford University Press.
51. Goldberg, D., & Williams, P. (1991). A user guide to the general health questionnaire. Berkshire: Nfer-Nelson.
52. Goldner, E. M., Hsu, L., Waraich, P., & Somers, J. M. (2002). Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 47(9), 833-843.
53. Goldstein, J. M. (1988). Gender differences in the course of schizophrenia. The American Journal of Psychiatry, 145(6), 684-689.
54. Goldstein, J. M., & Link, B. G. (1988). Gender and the expression of schizophrenia. Journal of Psychiatric Research, 22(2), 141-155.
55. Gottesman, I. I., & Shields, J. (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 58(1), 199-205.
56. Gottesman, I. I., & Shields, J. (1982). Schizophrenia: The epigenetic puzzle. New York: Cambridge University Press.
57. Green, A. I. (2000). What is the relationship between schizophrenia and substance abuse? The Harvard Mental Health Letter, 17(4), 8.
58. Grigoriadis, S., & Seeman, M. V. (2002). The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Canadian Journal of Psychiatry, 47(5), 437-442.
59. Grossman, L. S., Harrow, M., Rosen, C., & Faull, R. (2006). Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatric Services, 57(6), 844-850.
60. Grove, W. M., Andreasen, N. C., McDonald-Scott, P., Keller, M. B., & Shapiro, R. W. (1981). Reliability studies of psychiatric diagnosis. Theory and practice. Archives of General Psychiatry, 38(4), 408-413.
61. Gurling, H. M., Kalsi, G., Brynjolfson, J., Sigmundsson, T., Sherrington, R., Mankoo, B. S., et al. (2001). Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32. 2, 5q33. 2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23. 3-24 and 20q12. 1-11. 23. American Journal of Human Genetics, 68(3), 661-673.
62. Häfner, H., Riecher, A., Maurer, K., Löffler, W., Munk-Jørgensen, P., & Strömgren, E. (1989). How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychological Medicine, 19(4), 903-918.
63. Häfner, H., an der Heiden, W., Behrens, S., Gattaz, W. F., Hambrecht, M., Löffler, W., et al. (1998a). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin, 24(1), 99-113.
64. Häfner, H., Maurer, K., Löffler, W., an der Heiden, W., Munk-Jørgensen, P., Hambrecht, M., et al. (1998b). The ABC Schizophrenia Study: a preliminary overview of the results. Social Psychiatry and Psychiatric Epidemiology, 33(8), 380-386.
65. Hallonquist, J. D., Seeman, M. V., Lang, M., & Rector, N. A. (1993). Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry, 33(3), 207-209.
66. Hambrecht, M., & Häfner, H. (2000). Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. The Australian and New Zealand Journal of Psychiatry, 34(3), 468-475.
67. Hare, E. (1988). Schizophrenia as a recent disease. The British Journal of Psychiatry, 153, 521-531.
68. Harrison, P. J., & Owen, M. J. (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet, 361(9355), 417-419.
69. Heinimaa, M. L. (2000). On the grammar of "psychosis". Medicine, Health Care, and Philosophy, 3(1), 39-46.
70. Hochman, K. M., & Lewine, R. R. (2004). Age of menarche and schizophrenia onset in women. Schizophrenia Research, 69(2-3), 183-188.
71. Hollingshead, A., & Redlich, F. (1958). Social class and mental illness. New York: Wiley.
72. Isaac, M., Isaac, M., & Holloway, F. (2005). Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care. Human Psychopharmacology, 20(3), 207-210.
73. Jablensky, A. (1997). The 100-year epidemiology of schizophrenia. Schizophrenia Research, 28(2-3), 111-125.
74. Jablensky, A. (2000). Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience, 250(6), 274-285.
75. Jablensky, A. V., & Kalaydjieva, L. V. (2003). Genetic epidemiology of schizophrenia: phenotypes, risk factors, and reproductive behavior. The American Journal of Psychiatry, 160(3), 425-429.
76. Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., et al. (1992). Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study (20th ed.). Cambridge: Cambridge University Press.
77. Janzarik, W. (2003). The concept of psychosis and psychotic qualities. Der Nervenarzt, 74(1), 3-11.
78. Jones, P. B., Rantakallio, P., Hartikainen, A. L., Isohanni, M., & Sipila, P. (1998). Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. The American Journal of Psychiatry, 155(3), 355-364.
79. Kaplan, H., & Sadock, B. (1991). Synopsis of psychiatry (6th ed.). Baltimore: Williams & Wilkins.
80. Kaplan, H., & Sadock, B. (1998). Synopsis of psychiatry (8th ed.). Baltimore: Williams & Wilkins.
81. Kelly, B. D., Feeney, L., O'Callaghan, E., Browne, R., Byrne, M., Mulryan, N., et al. (2004). Obstetric adversity and age at first presentation with schizophrenia: evidence of a dose-response relationship. The American Journal of Psychiatry, 161(5), 920-922.
82. Kendell, R. E., Juszczak, E., & Cole, S. K. (1996). Obstetric complications and schizophrenia: a case control study based on standardised obstetric records. The British Journal of Psychiatry, 168(5), 556-561.
83. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8-19.
84. Kety, S. S., Wender, P. H., Jacobsen, B., Ingraham, L. J., Jansson, L., Faber, B., et al. (1994). Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Archives of General Psychiatry, 51(6), 442-455.
85. Kölsch, H., & Rao, M. L. (2002). Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders. Archives of Women's Mental Health, 5(3), 105-110.
86. Korhonen, S., Saarijärvi, S., & Aito, M. (1995). Successful estradiol treatment of psychotic symptoms in the premenstrual phase: a case report. Acta Psychiatrica Scandinavica, 92(3), 237-238.
87. Kramer, M. (1978). Population changes and schizophrenia 1970-1975. In L. Wynne, R. Cromwell & S. Matthysse (Eds.), The nature of schizophrenia-new approaches to research and treatment (pp. 545-571). New York: Wiley.
88. Kulkarni, J., Riedel, A., de Castella, A. R., Fitzgerald, P. B., Rolfe, T. J., Taffe, J., et al. (2001). Estrogen-a potential treatment for schizophrenia. Schizophrenia Research, 48(1), 137-144.
89. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921.
90. Leung, A., & Chue, P. (2000). Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica. Supplementum, 401, 3-38.
91. Levav, I., Kohn, R., Dohrenwend, B. P., Shrout, P. E., Skodol, A. E., Schwartz, S., et al. (1993). An epidemiological study of mental disorders in a 10-year cohort of young adults in Israel. Psychological Medicine, 23(3), 691-707.
92. Levinson, D. F., Levinson, M. D., Segurado, R., & Lewis, C. M. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: methods and power analysis. American Journal of Human Genetics, 73(1), 17-33.
93. Leweke, F. M., Gerth, C. W., & Klosterkötter, J. (2004). Cannabis-associated psychosis: current status of research. CNS Drugs, 18(13), 895-910.
94. Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. American Journal of Human Genetics, 73(1), 34-48.
95. Lindholm, E., Ekholm, B., Shaw, S., Jalonen, P., Johansson, G., Pettersson, U., et al. (2001). A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. American Journal of Human Genetics, 69(1), 96-105.
96. McGrath, J. J., & Welham, J. L. (1999). Season of birth and schizophrenia: a systematic review and meta-analysis of data from the Southern Hemisphere. Schizophrenia Research, 35(3), 237-242.
97. McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 2, 13.
98. McGue, M., Gottesman, I. I., & Rao, D. C. (1983). The transmission of schizophrenia under a multifactorial threshold model. American Journal of Human Genetics, 35(6), 1161-1178.
99. McGuffin, P., Farmer, A., & Gottesman, I. I. (1987). Is there really a split in schizophrenia? The genetic evidence. The British Journal of Psychiatry, 150, 581-592.
100. Messias, E. L., Chen, C., & Eaton, W. W. (2007). Epidemiology of schizophrenia: review of findings and myths. The Psychiatric Clinics of North America, 30(3), 323-338.
101. Moldin, S. O. (1997). The maddening hunt for madness genes. Nature Genetics, 17(2), 127-129.
102. Mueser, K. T., Bellack, A. S., & Blanchard, J. J. (1992). Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting and Clinical Psychology, 60(6), 845-856.
103. Myers, J. K., & Weissman, M. (1986). Psychiatric disorders in a U. S. urban community: The new haven study. In M. M. Weissman, J. K. Myers & C. E. Ross (Eds.), Community surveys of psychiatric disorders (pp. 155-175). New Brunswick: Rutgers University Press.
104. Myers, J. K., Weissman, M. M., Tischler, G. L., Holzer, C. E., Leaf, P. J., Orvaschel, H., et al. (1984). Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Archives of General Psychiatry, 41(10), 959-967.
105. Nicole, L., Lesage, A., & Lalonde, P. (1992). Lower incidence and increased male: female ratio in schizophrenia. The British Journal of Psychiatry, 161, 556-557.
106. Nicolson, R., Malaspina, D., Giedd, J. N., Hamburger, S., Lenane, M., Bedwell, J., et al. (1999). Obstetrical complications and childhood-onset schizophrenia. The American Journal of Psychiatry, 156(10), 1650-1652.
107. Nimgaonkar, V. L. (1997). In defense of genetic association studies. Molecular Psychiatry, 2(4), 275-277.
108. O'Callaghan, E., Sham, P., Takei, N., Glover, G., & Murray, R. M. (1991). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet, 337(8752), 1248-1250.
109. O'Donovan, M. C., & Owen, M. J. (1999). Candidate-gene association studies of schizophrenia. American Journal of Human Genetics, 65(3), 587-592.
110. Owen, M. J., Cardno, A. G., & O'Donovan, M. C. (2000). Psychiatric genetics: back to the future. Molecular Psychiatry, 5(1), 22-31.
111. Peralta, V., & Cuesta, M. J. (2003). The nosology of psychotic disorders: a comparison among competing classification systems. Schizophrenia Bulletin, 29(3), 413-425.
112. Peralta, V., Cuesta, M. J., Giraldo, C., Cardenas, A., & Gonzalez, F. (2002). Classifying psychotic disorders: issues regarding categorial vs. dimensional approaches and time frame to assess symptoms. European Archives of Psychiatry and Clinical Neuroscience, 252(1), 12-18.
113. Rajkumar, S., Padmavati, R., Thera, R., et al. (1993). Incidence of schizophrenia in an urban community in Madras. Indian Journal of Psychiatry, 35, 18-21.
114. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA: The Journal of the American Medical Association, 264(19), 2511-2518.
115. Riecher-Rössler, A. (2002). Oestrogen effects in schizophrenia and their potential therapeutic implications-review. Archives of Women's Mental Health, 5(3), 111-118.
116. Riecher-Rössler, A., & Häfner, H. (1993). Schizophrenia and oestrogens-is there an association? European Archives of Psychiatry and Clinical Neuroscience, 242(6), 323-328.
117. Riecher-Rössler, A., Häfner, H., Stumbaum, M., Maurer, K., & Schmidt, R. (1994). Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bulletin, 20(1), 203-214.
118. Ring, N., Tantam, D., Montague, L., Newby, D., Black, D., & Morris, J. (1991). Gender differences in the incidence of definite schizophrenia and atypical psychosis-focus on negative symptoms of schizophrenia. Acta Psychiatrica Scandinavica, 84(6), 489-496.
119. Risch, N. (1990). Linkage strategies for genetically complex traits. II. The power of affected relative pairs. American Journal of Human Genetics, 46(2), 229-241.
120. Robins, L. N., Helzer, J. E., Croughan, J., & Ratcliff, K. S. (1981). National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Archives of General Psychiatry, 38(4), 381-389.
121. Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., et al. (1988). The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45(12), 1069-1077.
122. Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2(5), e141.
123. Sartorius, N., Jablensky, A., Korten, A., Ernberg, G., Anker, M., Cooper, J. E., et al. (1986). Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychological Medicine, 16(4), 909-928.
124. Schaeffer, J. M., & Hsueh, A. J. (1979). 2-Hydroxyestradiol interaction with dopamine receptor binding in rat anterior pituitary. The Journal of Biological Chemistry, 254(13), 5606-5608.
125. Schultz, S. K., Miller, D. D., Oliver, S. E., Arndt, S., Flaum, M., & Andreasen, N. C. (1997). The life course of schizophrenia: age and symptom dimensions. Schizophrenia Research, 23(1), 15-23.
126. Schwab, S. G., Hallmayer, J., Albus, M., Lerer, B., Eckstein, G. N., Borrmann, M., et al. (2000). A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Molecular Psychiatry, 5(6), 638-649.
127. Seeman, M. V. (1982). Gender differences in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 27(2), 107-112.
128. Seeman, M. V. (1983). Interaction of sex, age, and neuroleptic dose. Comprehensive Psychiatry, 24(2), 125-128.
129. Seeman, M. V. (1998). Narratives of twenty to thirty year outcomes in schizophrenia. Psychiatry, 61(3), 249-261.
130. Shifman, S., Bronstein, M., Sternfeld, M., Pisanté-Shalom, A., Lev-Lehman, E., Weizman, A., et al. (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 71(6), 1296-1302.
131. Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C., & Gur, R. C. (1992). Gender differences in the clinical expression of schizophrenia. Schizophrenia Research, 7(3), 225-231.
132. Smit, F., Bolier, L., & Cuijpers, P. (2004). Cannabis use and the risk of later schizophrenia: a review. Addiction (Abingdon, England), 99(4), 425-430.
133. Spitzer, R. L., & Fleiss, J. L. (1974). A re-analysis of the reliability of psychiatric diagnosis. The British Journal of Psychiatry: The Journal of Mental Science, 125, 341-347.
134. Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Archives of General Psychiatry, 49(8), 624-629.
135. Star, S. A. (1950). The screening of psychoneurotics in the Army: Technical development of tests. New York: Wiley.
136. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics, 71(4), 877-892.
137. Straub, R. E., MacLean, C. J., O'Neill, F. A., Burke, J., Murphy, B., Duke, F., et al. (1995). A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nature Genetics, 11(3), 287-293.
138. Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., et al. (2002). Genetic variation in the 6p22. 3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics, 71(2), 337-348.
139. Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry, 60(12), 1187-1192.
140. Susser, E., Neugebauer, R., Hoek, H. W., Brown, A. S., Lin, S., Labovitz, D., et al. (1996). Schizophrenia after prenatal famine. Further evidence. Archives of General Psychiatry, 53(1), 25-31.
141. Suvisaari, J. M., Haukka, J. K., Tanskanen, A. J., & Lönnqvist, J. K. (1999). Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Archives of General Psychiatry, 56(8), 733-740.
142. Swofford, C. D., Scheller-Gilkey, G., Miller, A. H., Woolwine, B., & Mance, R. (2000). Double jeopardy: schizophrenia and substance use. The American Journal of Drug and Alcohol Abuse, 26(3), 343-353.
143. Takei, N., Lewis, G., Sham, P. C., & Murray, R. M. (1996). Age-period-cohort analysis of the incidence of schizophrenia in Scotland. Psychological Medicine, 26(5), 963-973.
144. Thorup, A., Waltoft, B. L., Pedersen, C. B., Mortensen, P. B., & Nordentoft, M. (2007). Young males have a higher risk of developing schizophrenia: a Danish register study. Psychological Medicine, 37(4), 479-484.
145. Torrey, E. F. (1988). Stalking the schizovirus. Schizophrenia Bulletin, 14(2), 223-229.
146. Torrey, E. F., Rawlings, R., & Waldman, I. N. (1988). Schizophrenic births and viral diseases in two states. Schizophrenia Research, 1(1), 73-77.
147. van Os, J., Gilvarry, C., Bale, R., van Horn, E., Tattan, T., White, I., et al. (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine, 29(3), 595-606.
148. van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology, 156(4), 319-327.
149. van Os, J., Rutten, B. P., & Poulton, R. (2008). Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia Bulletin, 34(6), 1066-1082.
150. van Zelst, C. (2008). Which environments for G x E? A user perspective on the roles of trauma and structural discrimination in the onset and course of schizophrenia. Schizophrenia Bulletin, 34(6), 1106-1110.
151. Veen, N. D., Selten, J., van der Tweel, I., Feller, W. G., Hoek, H. W., & Kahn, R. S. (2004). Cannabis use and age at onset of schizophrenia. The American Journal of Psychiatry, 161(3), 501-506.
152. Verdoux, H., Geddes, J. R., Takei, N., Lawrie, S. M., Bovet, P., Eagles, J. M., et al. (1997a). Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. The American Journal of Psychiatry, 154(9), 1220-1227.
153. Verdoux, H., Takei, N., Cassou de Saint-Mathurin, R., Murray, R. M., & Bourgeois, M. L. (1997b). Seasonality of birth in schizophrenia: the effect of regional population density. Schizophrenia Research, 23(2), 175-180.
154. Weiser, M., Reichenberg, A., Rabinowitz, J., Kaplan, Z., Caspi, A., Yasvizky, R., et al. (2003). Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia. Biological Psychiatry, 54(6), 655-660.
155. WHO. (1948). Manual of the international classification of diseases, injuries and causes of death (6th ed., Vol. 1). Geneva: World Health Organization.
156. WHO. (1992). The ICD-10 classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines (10th ed.). Geneva: World Health Organization.
157. WHO. (1993). The ICD-10 classification of mental and behavioral disorders: Diagnostic criteria for research (10th ed.). Geneva: World Health Organization.
158. Williams, N. M., Bowen, T., Spurlock, G., Norton, N., Williams, H. J., Hoogendoorn, B., et al. (2002). Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Molecular Psychiatry, 7(5), 508-514.
159. Wing, J., Cooper, J., & Sartorius, N. (1974). The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press.
160. Wing, J. K., Babor, T., Brugha, T., Burke, J., Cooper, J. E., Giel, R., et al. (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry, 47(6), 589-593.
161. World Health Organization (WHO). (1990). Compsite International Diagnostic Interview (CIDI) (1st ed.). Geneva: World Health Organization.
162. Yui, K., Ikemoto, S., Ishiguro, T., & Goto, K. (2000). Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Annals of the New York Academy of Sciences, 914, 1-12.
163. Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal (Clinical Research Ed.), 325(7374), 1199.